Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For mental health providers:
- People who work as mental health providers
- People who treat Latino cancer patients and/or survivors
- People who have at least 3 years of experience providing mental health or emotional support services to cancer patients and/or survivors
- People who are able to read in Spanish
For cancer patients:
- People whose cancer has been confirmed through a pathology test (tissue or cell testing) and who have a solid tumor cancer (either a new or most recent diagnosis)
- People diagnosed with stage I, II, or III cancer
- People who are currently receiving cancer treatment such as chemotherapy, radiation, or immunotherapy — or who finished that treatment within the past year
- People aged 21 or older
- People who live in the mainland United States or Puerto Rico
- People who identify as Latino/a or Hispanic
- People whose preferred language is Spanish
- People who speak Spanish "Well" or "Very well"
- People who are experiencing fatigue (tiredness) and disturbed sleep, based on a score of 3 or higher on a standard symptom questionnaire called the MD Anderson Symptom Inventory
Who may not be able to join:
- People whose treating doctor or study staff determines that a cognitive condition — such as confusion (delirium) or memory loss (dementia) — would prevent them from fully understanding and participating in the study
- People who have had certain health conditions in the past 12 months that are known to cause fatigue or poor sleep, including thyroid problems, sleep apnea, chronic obstructive pulmonary disease (a lung condition), neuromuscular disease, or alcohol or drug misuse
- Women who are pregnant or breastfeeding
- People who give any response indicating suicidal risk on a standardised safety questionnaire called the Columbia-Suicide Severity Rating Scale
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rosario Costas Muniz, PhD, Memorial Sloan Kettering Cancer Center
Phone: 646-888-8062
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants who complete at least 5 DESCANSO sessions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.